69th Annual Coccidioidomycosis Study Group Scientific Conference
Project Number1R13AI189200-01
Contact PI/Project LeaderLAKE, DOUGLAS F.
Awardee OrganizationARIZONA STATE UNIVERSITY-TEMPE CAMPUS
Description
Abstract Text
PROJECT SUMMARY
Funds are requested to provide partial support for the 69th Annual Conference of Coccidioidomycosis Study
Group (CSG) to be held on April 5-6, 2025, hosted by the Arizona State University Health Futures Center in
Phoenix, Arizona. CSG prides itself on bringing the largest group of coccidioidomycosis researchers together
to share the latest clinical and basic laboratory findings, provide opportunities for collaboration, and especially
to promote the development of junior trainees. Researchers, physicians, veterinarians, other healthcare
providers, epidemiologists, and various trainees (students/residents/fellows/postdocs) from over 30
laboratories have attended annually. The CSG typically rotates between Arizona and California, but the 68th
CSG was in San Antonio which is at the edge of the endemic region. A growing number of medical mycologists
have attended this meeting, leading to its longevity and significance over the past 68 years.
Although the meeting format has evolved over the years, the current format focuses on oral and
poster presentations by trainees regarding their most exciting and impactful research data. The small
group setting provides a welcoming environment that successfully promotes discussion and constructive
feedback for trainees. The program includes seven scientific sessions with 38-40 slots for trainees’ oral
presentations, a poster session, a keynote speaker, a business meeting hour, and a sponsor-funded banquet.
The small group setting in the planned program and attendance by PIs and trainees is excellent for
networking and promoting trainee development Dr. Thuy Le, a renowned medical mycologist from DukeUniversity in the area of talaromycosis has accepted our invitation to be the 2025 keynote speaker. We request
10 travel awards ($750 each) for trainees to present in-person and to encourage more early career scientists to
attend the meeting. Travel award recipients will be selected on the basis of their application for (i) need of
travel support and (ii) quality and merit of their research. Aligning with DEI requirements, we will also assign a
higher priority for women and minority trainees as well as anyone challenged with a physical disability.
Public Health Relevance Statement
PROJECT NARRATIVE
The Goal of this R13 Scientific Conference application is to partially fund the 69th annual Coccidioidomycosis
Study Group at the Arizona State University Health Futures Center in Phoenix, AZ. Phoenix is in Maricopa
county, AZ which has more yearly cases of coccidioidomycosis (Valley Fever) diagnosed than any other
location in the world. This meeting is an opportunity for clinical and basic science researchers to exchange
information and for young investigators and trainees to present their findings to the Valley Fever community in
a diverse, equitable and inclusive environment.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AreaArizonaAwardAwarenessBasic ScienceBiological MarkersBiologyBusinessesCaliforniaCareer ChoiceCitiesClinicalClinical SciencesCoccidioidesCoccidioidomycosisCollaborationsCommunicable DiseasesCommunitiesCountyDataDevelopmentDiagnosisDiseaseEnvironmentEpidemiologistEpidemiologyEquityExpenditureFacultyFeedbackFosteringFundingFutureGeographic LocationsGeographyGoalsGrantHealthHealth CareHealth PersonnelHispanic-serving InstitutionHourImmune responseInstitutionInternationalLaboratoriesLaboratory FindingLearningLocationLongevityMedicalMentorsMexicoNamesNational Institute of Allergy and Infectious DiseaseNucleic AcidsOralParticipantPersonsPhysiciansPlanet EarthPostdoctoral FellowProtein ArrayProteinsProteomePublishingReportingResearchResearch PersonnelRotationSchoolsScientistSerologySouth AmericaStudentsThe science of MycologyTravelUnited StatesUnited States National Institutes of HealthUniversitiesVeterinariansWomanWorkcareerclinical centerdesert feverdiversity and inclusionethnic diversitygraduate studentimprovedinnovationmedical schoolsmeetingsminority traineenewsnovelphysically handicappedpostersprogramssymposiumtoolundergraduate student
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
943360412
UEI
NTLHJXM55KZ6
Project Start Date
27-January-2025
Project End Date
31-December-2025
Budget Start Date
27-January-2025
Budget End Date
31-December-2025
Project Funding Information for 2025
Total Funding
$6,000
Direct Costs
$6,000
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2025
National Institute of Allergy and Infectious Diseases
$6,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R13AI189200-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R13AI189200-01
Patents
No Patents information available for 1R13AI189200-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R13AI189200-01
Clinical Studies
No Clinical Studies information available for 1R13AI189200-01
News and More
Related News Releases
No news release information available for 1R13AI189200-01
History
No Historical information available for 1R13AI189200-01
Similar Projects
No Similar Projects information available for 1R13AI189200-01